LGL. Gabriels

L. Gabriels

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


L. Gabriels has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Deep brain stimulation and anterior capsulotomy: The question of autonomy

    by S. Raymaekers, Z. Van Duppen, K. Demyttenaere, L. Luyten, L. Gabriels, B. Nuttin, C. Bervoets

    Introduction: In carefully selected treatment-refractory patients with obsessive compulsive disorder (OCD), deep brain stimulation (DBS) or anterior capsulotomy (AC) might be considered as a possible treatment. However, the direct intervention in the brain can raise questions about autonomy. Do patients still feel like they are in control of their actions when their behavior is changed by a surgical intervention?Objective/aims: To examine in both AC and DBS patients whether these intervention influenced perception of autonomy. We aimed to discover any differences in these perceptions when comparing AC and DBS patients.Methods: We conducted semi-structured interviews with AC and DBS patients. Interviews were recorded digitally and transcribed verbatim. We analyzed interviews in an iterative process based on grounded theory principles.Results: We interviewed 10 DBS patients and 6 AC patients. Sense of agency (the awareness that one is the author of his/her own actions) did not seem to be diminished by AC or DBS. However, especially DBS patients are aware of their dependency on a device for their well-being. Another important theme is authenticity (in how far patients perceive their actions and thoughts as matching their self-concept). Feelings of authenticity can be disturbed especially in cases of induced hypomania (for DBS) or apathy (for AC). OCD itself also has an impact on autonomy as patients describe a lack of freedom due to their disorder.Conclusion: Despite extensive changes in emotions, behavior and even personal identity after DBS or AC surgery, perceived autonomy was not greatly altered in these OCD patients.Disclosure of interest: Medtronic provided grants for research, education, and traveling to B. Nuttin and L. Gabriëls, who hold the Medtronic Chair for Stereotactic Neurosurgery in Psychiatric Disorders at KU Leuven. S. Raymaekers is supported by this Chair. B. Nuttin co-owns a patent on DBS in OCD.


    • 1 January 2013
      • Vol. 55  (3) , 203-8

    [Deep brain stimulation in a patient with ocd and the intensive pre- and post-operative psychiatric/psychotherapeutic follow-up. A case study].

    by P Corveleyn, B Nuttin, L Gabriëls

    Deep brain stimulation (DBS) is a neurosurgical intervention carried out in meticulously selected patients with a therapy-resistant obsessive-compulsive disorder (OCD). We describe the pre- and post-operative psychiatric care given to a 51-year-old woman before, during and after treatment with deep brain stimulation. The psychiatric follow-up included an intensive search for the optimal stimulation parameters, and considerable attention was given to psycho-education, psychotherapy and counselling. The procedure resulted in a marked improvement in the patient's OCD and made it easier for the patient to re-construct a meaningful life.


  • Deep brain stimulation for treatment‐refractory obsessive‐compulsive disorder: psychopathological and neuropsychological outcome in three cases

    by L. Gabriëls, P. Cosyns, B. Nuttin, H. Demeulemeester, J. Gybels

    Objective:  Investigation of deep brain stimulation (DBS) as a last‐resort treatment alternative to capsulotomy in treatment‐refractory obsessive‐compulsive disorder (OCD).Method:  Prospective single‐case based design with evaluation of DBS impact on emotions, behaviour, personality traits and executive function in three patients with OCD.Results:  Two patients experienced sustained improvement of OCD symptoms with DBS. Yale‐Brown Obsessive‐Compulsive Scale (Y‐BOCS) dropped 12 points and 23 points to baseline and Y‐BOCS self‐rating scale (Y‐BOCS‐SRS) and Profile of Mood States (POMS) for depression and tension decreased with increasing stimulation amplitude. Total Maladjustment Score on the Brief Psychiatric Rating Scale reduced with 44 and 59% to baseline. Reduction in psychopathology was sustained under continuous stimulation. No deleterious impact of DBS on neuropsychological testing or personality traits measured on a self‐rated personality inventory was detected.Conclusion:  These preliminary findings demonstrate that DBS may have important therapeutic benefits on psychopathology in OCD. No harmful side‐effects were detected during follow‐up (33/33/39 months, respectively).


    • 1 January 2003
      • Vol. 65  (6) , 385

    Deep brain stimulation in treatment refractory obsessive compulsive disorder.

    by P Cosyns, L Gabriels, B Nuttin

    Obsessive-compulsive disorder is a worldwide psychiatric disorder with a lifetime prevalence of 2% and mainly characterized by obsessional ideas and compulsive behaviors and rituals. Many patients show improvement under cognitive behavioral and/or pharmacological treatment. A minority of patients is refractory to all available therapy and may benefit from capsulotomy. This study aims to investigate deep brain stimulation (DBS) as a last resort treatment alternative to capsulotomy in treatment refractory obsessive-compulsive disorder. Eight patients have been implanted bilaterally in the anterior limbs of the internal capsules with a quadripolar electrode. This paper presents the results of the first 4 operated patients. Acute deep brain stimulation displays an immediate improvement of the speech, mood, eye contact and motor function. Chronic deep brain stimulation improves significantly the obsessional and compulsive symptomatology in three out of the four patients. This study definitely needs replication, but the results are promising. Reversible deep brain stimulation may improve the symptomatology of treatment refractory OCD patients, without significant side effects.